• 1
    Asconapé J, Diedrich A, DellaBadia J., Gabapentin-associated myoclonus [Abstract]. Neurology 1995;45(suppl 4):A24950.
  • 2
    Reeves AL, So EL, Sharbrough FW, Krahn LE, Movement disorders associated with the use of gabapentin. Epilepsia 1996;37:98890.
  • 3
    Vossler DG, Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin. Neurology 1996;46:8523.
  • 4
    Pranzatelli MR, Serotonin and human myoclonus. Arch Neurol 1994;51:60517.
  • 5
    Rao ML, Clarenbach P, Vahlensieck M, Krätzschmar S., Gabapentin augments whole blood serotonin in healthy young men. J Neural Transm 1988;73:12934.
  • 6
    Taylor CP, Mechanisms of action of new anti-epileptic drugs. In: ChadwickD, ed. New trends in epilepsy management: the role of gabapentin. London : Royal Society of Medicine Services, 1993:1340.
  • 7
    Goldlust A, Su TZ, Welty DF, Taylor CP, Oxender DL, Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res 1995;22:111.
  • 8
    Kanthasamy AG, Vu TQ, Yun RJ, Truong DD, Antimyoclonic effect of gabapentin in a posthypoxic animal model of myoclonus. Eur J Clin Pharmacol 1996;297:21924.